Imperial Clinical Trials Unit-Cancer (ICTU-Ca), led by Professor Michael Seckl, through its close association with the Imperial Experimental Cancer Medicine Centre and Cancer Research UK Imperial Centre provides a core accredited environment to develop and conduct cancer clinical trials led from Imperial College. With a major focus on precision medicine and proof of concept clinical trials, ICTU-Ca currently undertakes phase Ib to phase III trials across multiple sites of disease (including lung, gastrointestinal and gynaecological).  The cancer portfolio exploits the research expertise in the Division of Cancer to enable trials that include new and exciting imaging modalities, translational research initiatives and innovative study designs as they evolve.

The ICTU-Ca team provide a comprehensive service to support potential clinical principal investigators in trial development from concept to trial design, robust peer review, protocol development, statistical support, trial costings, application preparation then submission and subsequently successful trial set-up, running and close down.

Therapeutic Area peer review group

• Michael Seckl
• Philip D Badman
• Iain A McNeish
• Andrea Rockall
• Alan Melcher
• David J Pinato
• Naina R Patel
• Nicholas A Johnson
• Emily Pickford
• Maria Martinez